Patents by Inventor Luis Diaz

Luis Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210156136
    Abstract: A multistory building construction system comprising at least one base plate including a centrally disposed sleeve extending vertically from a top surface thereof and configured to engage an interior portion of a bottom end of at least one first-floor column including a cap plate disposed on a top end thereof with a centrally disposed sleeve extending vertically therefrom configured to engage an exterior portion of a bottom end of at least one upper-floor column and configured to support a decking for a concrete floor, the first-floor column and upper-floor column further including at least one sheer tab for attachment of beams for support of the decking.
    Type: Application
    Filed: February 4, 2021
    Publication date: May 27, 2021
    Inventors: Dean Allmon, Luis Diaz
  • Patent number: 11000363
    Abstract: Disclosed herein is an implantable accommodative IOL system for insertion into an eye of a patient, the system comprising: an optical element and a housing including an opaque frame. The optical element comprises an optical lens having variable optical power, and the opaque frame is circumferentially disposed around a periphery of the optical element.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: May 11, 2021
    Assignee: Alcon Inc.
    Inventors: John A. Campin, Costin E. Curatu, Luis Diaz-Santana, Nicholas James Wooder, Richard Lintern, Rita Stella, Samuel Pollock
  • Publication number: 20210130463
    Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.
    Type: Application
    Filed: December 22, 2020
    Publication date: May 6, 2021
    Inventors: Luis Diaz, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Dung Le, Drew M. Pardoll, Suzanne L. Topalian
  • Publication number: 20210130908
    Abstract: TERT promoter mutations occur in both papillary and flat lesion bladder cancers, are the most frequent genetic alterations identified to date in noninvasive precursor lesions of the bladder, are detectable in urine, and appear to be strongly associated with bladder cancer recurrence. The TERT promoter mutations are useful urinary biomarker for both the early detection and monitoring of bladder neoplasia.
    Type: Application
    Filed: November 13, 2020
    Publication date: May 6, 2021
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Luis Diaz, Nickolas Papadopoulos, George J. Netto, Ralph Hruban, Isaac A. Kinde
  • Publication number: 20210107978
    Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.
    Type: Application
    Filed: December 22, 2020
    Publication date: April 15, 2021
    Inventors: Luis Diaz, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Dung Le, Drew M. Pardoll, Suzanne L. Topalian
  • Patent number: 10974380
    Abstract: The multi-tool wrench is a single tool that provides multiple tools useful by a craftsman. The multi-tool wrench comprises a first tool half and a second tool half that are removably coupled by a quick disconnect. The halves may be decoupled for use in confined spaces or to simultaneously use tools from each half. The first tool half provides an adjustable wrench and two pivoting hex keys. The adjustable wrench has a reversible lower jaw to convert the wrench into a pipe wrench. The second tool half provides a set of three open end wrenches, a pivoting flat blade screwdriver, and a pivoting cross head screwdriver. The open end wrenches and hex keys may be sized to provide common tools needed in a specific occupation or field. As a non-limiting example, the tools may be common sizes used by a welder.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: April 13, 2021
    Inventor: Luis Diaz
  • Patent number: 10975477
    Abstract: A method of electrochemically reducing CO2 comprises introducing a first feed stream comprising H2O to a positive electrode of an electrolysis cell comprising the positive electrode, a negative electrode, and a proton conducting membrane. A second feed stream comprising a solvent and a non polar form of a switchable polarity material is directed into a CO2 capture apparatus. A third feed stream comprising CO2 is directed into the CO2 capture apparatus to interact with the second feed stream and form a first product stream comprising the solvent and a polar form of the switchable polarity material. The first product stream is introduced to the negative electrode. A potential difference is applied between the positive electrode and the negative electrode to convert the polar form of the switchable polarity material into CO2 and the non-polar form and to form products from the CO2 and the solvent. A CO2 treatment system is also described.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: April 13, 2021
    Assignee: Battelle Energy Alliance, LLC
    Inventors: Tedd E. Lister, Eric J. Dufek, Aaron D. Wilson, Luis A. Diaz Aldana, Birendra Adhikari, Ningshengjie Gao
  • Patent number: 10934356
    Abstract: Blockade of immune checkpoints such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed death-1 (PD-1) shows promise in patients with cancer. Inhibitory antibodies directed at these receptors have been shown to break immune tolerance and promote anti-tumor immunity. These agents work particularly well in patients with a certain category of tumor. Such tumors may be particularly susceptible to treatment because of the multitude of neoantigens which they produce.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: March 2, 2021
    Assignee: The Johns Hopkins University
    Inventors: Luis Diaz, Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Dung Le, Drew M. Pardoll, Suzanne L. Topalian
  • Publication number: 20210047708
    Abstract: A method of selectively recovering palladium from a palladium-containing material comprises providing a leaching solution comprising hydrochloric acid, hydrogen peroxide, and an iron salt comprising one or both of ferric chloride or ferrous chloride and contacting a palladium-containing material with the leaching solution to dissolve palladium from the palladium-containing material. Related methods of selectively recovering palladium from a palladium-containing material are also disclosed.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 18, 2021
    Inventors: Tedd E. Lister, Luis A. Diaz Aldana
  • Patent number: 10900088
    Abstract: Clinical management of human cancer is dependent on the accurate monitoring of residual and recurrent tumors. We have developed a method, called personalized analysis of rearranged ends (PARE), which can identify translocations in solid tumors. Analysis of four colorectal and two breast cancers revealed an average of nine rearranged sequences (range 4 to 15) per tumor. Polymerase chain reaction with primers spanning the breakpoints were able to detect mutant DNA molecules present at levels lower than 0.001% and readily identified mutated circulating DNA in patient plasma samples. This approach provides an exquisitely sensitive and broadly applicable approach for the development of personalized biomarkers to enhance the clinical management of cancer patients.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: January 26, 2021
    Assignee: The Johns Hopkins University
    Inventors: Bert Volgelstein, Kenneth W. Kinzler, Victor Velculescu, Luis Diaz, Rebecca J. Leary
  • Patent number: 10870890
    Abstract: TERT promoter mutations occur in both papillary and flat lesion bladder cancers, are the most frequent genetic alterations identified to date in noninvasive precursor lesions of the bladder, are detectable in urine, and appear to be strongly associated with bladder cancer recurrence. The TERT promoter mutations are useful urinary biomarker for both the early detection and monitoring of bladder neoplasia.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: December 22, 2020
    Assignee: The Johns Hopkins University
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Luis Diaz, Nickolas Papadopoulos, George J. Netto, Ralph Hruban, Isaac A. Kinde
  • Publication number: 20200378106
    Abstract: A multistory building construction system comprising at least one base plate comprising a centrally disposed sleeve extending vertically from a top surface thereof and configured to engage an interior portion of a bottom end of at least one first-floor column comprising a cap plate disposed on a top end thereof with a centrally disposed sleeve extending vertically therefrom configured to engage an exterior portion of a bottom end of at least one upper-floor column and configured to support a decking for a concrete floor and configured so that a top end of the sleeve may be used as a benchmark for pouring the concrete floor, the first-floor column and the upper-floor column further comprising at least one sheer tab for attachment of beams for support of the decking.
    Type: Application
    Filed: May 28, 2020
    Publication date: December 3, 2020
    Inventors: CHARLES POST, DAYMON ALLMAN, LUIS DIAZ
  • Publication number: 20200370123
    Abstract: DNA containing somatic mutations is highly tumor specific and thus, in theory, can provide optimum markers. However, the number of circulating mutant gene fragments is small compared to the number of normal circulating DNA fragments, making it difficult to detect and quantify them with the sensitivity required for meaningful clinical use. We apply a highly sensitive approach to quantify circulating tumor DNA (ctDNA) in body samples of patients. Measurements of ctDNA can be used to reliably monitor tumor dynamics in subjects with cancer, especially those who are undergoing surgery or chemotherapy. This personalized genetic approach can be generally applied.
    Type: Application
    Filed: December 19, 2019
    Publication date: November 26, 2020
    Inventors: Frank Diehl, Luis Diaz, Kenneth W. Kinzler, Bert Vogelstein, Kerstin Schmidt
  • Publication number: 20200253421
    Abstract: The present inventions provide, among other things, tapered burner tubes having raised gas ports and a smooth interior surface free from obstructions. Venturi members creating a smooth flow of the gas/air mixture along the top of the burner tube are also provided.
    Type: Application
    Filed: April 29, 2020
    Publication date: August 13, 2020
    Applicant: Weber-Stephen Products LLC
    Inventors: J. Michael Alden, Mohammed Shoeb, Kevin James Schmeski, Luis Diaz, Jose Ignacio Mugica, Isabel Alava, Inigo Albizuri
  • Publication number: 20200255958
    Abstract: A method of electrochemically reducing CO2 comprises introducing a first feed stream comprising H2O to a positive electrode of an electrolysis cell comprising the positive electrode, a negative electrode, and a proton conducting membrane. A second feed stream comprising a solvent and a non polar form of a switchable polarity material is directed into a CO2 capture apparatus. A third feed stream comprising CO2 is directed into the CO2 capture apparatus to interact with the second feed stream and form a first product stream comprising the solvent and a polar form of the switchable polarity material. The first product stream is introduced to the negative electrode. A potential difference is applied between the positive electrode and the negative electrode to convert the polar form of the switchable polarity material into CO2 and the non-polar form and to form products from the CO2 and the solvent. A CO2 treatment system is also described.
    Type: Application
    Filed: September 28, 2018
    Publication date: August 13, 2020
    Inventors: Tedd E. Lister, Eric J. Dufek, Aaron D. Wilson, Luis A. Diaz Aldana, Birendra Adhikari, Ningshengjie Gao
  • Publication number: 20200248244
    Abstract: The present disclosure involves ctDNA assays that interrogate many regions from a single sample with high precision and accuracy, while evaluating multiple forms of cancer-related genomic alterations including sequence mutations and structural alterations. The disclosure provides simplified yet robust methods that achieve high sensitivity and specificity by analyzing cancer genes using a limited pool of non-unique barcodes in combination with endogenous barcodes. Samples are captured and sequenced using high coverage next-generation sequencing to allow tumor-specific somatic mutations, amplifications, and translocations to be identified.
    Type: Application
    Filed: November 14, 2017
    Publication date: August 6, 2020
    Inventors: Mark Sausen, Victor Velculescu, Luis Diaz
  • Patent number: 10698200
    Abstract: An optical projection system provides part of a display system that presents a displayed virtual image at a predetermined distance in front of a viewing position. Said display system comprises a projection system and a primary reflecting optic that deflects an off-axis incoming optical signal from the projection system toward the viewing position. Said projection system is arranged to provide an adapted output image signal that compensates for optical aberration effects introduced by the reflecting optic to ensure provision of a reduced aberration display image to the viewing position, and where the reflecting optic comprises a grating structure.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: June 30, 2020
    Assignee: The Technology Partnership Plc
    Inventors: Neil Griffin, Nick Wooder, Luis Diaz-Santana
  • Publication number: 20200190081
    Abstract: The present invention relates to meta substituted phenylpyrazolo- and phenylpyrrolo-pyridazine derivatives having dual pharmacological activity towards both the ?2? subunit, in particular the ?2?-1 subunit, of the voltage-gated calcium channel and the NET receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.
    Type: Application
    Filed: November 30, 2017
    Publication date: June 18, 2020
    Inventors: Marina VIRGILI-BERNADO, Monica ALONSO-XALMA, Carmen ALMANSA-ROSALES, José-Luis DÍAZ-FERNÁNDEZ
  • Patent number: 10667648
    Abstract: The present inventions provide, among other things, tapered burner tubes having raised gas ports and a smooth interior surface free from obstructions. Venturi members creating a smooth flow of the gas/air mixture along the top of the burner tube are also provided.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: June 2, 2020
    Assignee: Weber-Stephen Products LLC
    Inventors: J. Michael Alden, Mohammed Shoeb, Kevin James Schmeski, Luis Diaz, Jose Ignacio Mugica, Isabel Alava, Inigo Albizuri
  • Publication number: 20200160939
    Abstract: Cancer immunology provides promising new avenues for cancer treatment but validation of potential neoantigens to target is costly and expensive. Analysis of MHC binding affinity, antigen processing, similarity to known antigens, predicted expression levels (as mRNA or proteins), self-similarity, and mutant allele frequency, provides screening method to identify and prioritize candidate neoantigens using sequencing data. Methods of the invention thereby save time and money by identifying the priority candidate neoantigens for further experimental validation.
    Type: Application
    Filed: December 31, 2019
    Publication date: May 21, 2020
    Inventors: Victor Velculescu, Theresa Zhang, James Robert White, Luis Diaz